Monoceros Biosystems, a leading bioinformatics/computational biology provider, is pleased to announce the appointment of Regan Lohman to its Board of Directors

We are thrilled to announce the appointment of Regan Lohman to our Board. Regan is the founder & CEO of Lohman & Associates, Inc., a leading life science focused, outsourced finance and accounting firm. With 16 years of extensive experience in accounting, finance, and auditing, Regan brings a wealth of expertise to our board. Regan’s collaborative approach has seen her partner with companies across various stages of growth, providing invaluable support as CFO, facilitating debt and equity transactions, and implementing operational efficiencies within finance departments. Her journey has encompassed the full spectrum of startup experiences, from IPO to wind-down.

Prior to establishing Lohman & Associates, Regan honed her skills in Ernst & Young LLP’s audit practice. Subsequently, she has lent her expertise to startups spanning diverse industries such as technology, biotechnology, renewable energy, CPG, advertising, and professional services. Regan holds a B.B.A. in Accounting from the University of Iowa and an M.S. in Accountancy from the University of Missouri, Kansas City.

Adam Pavlicek, PhD, CEO of Monoceros Biosystems LLC, remarked, ” As we pursue our mission of providing unrivalled bioinformatics services that surpass abilities of best largest biopharma to biotech companies of all sizes, it is imperative that we ensure our scientific excellence is complemented by world class operational and financial acumen. Regan has previously provided invaluable strategic insights, and I am confident in her ability to propel Monoceros to its full potential.”

In the words of Regan herself, “I am honored to join the board of Monoceros. I am passionate about leveraging my experience to contribute to the strategic direction and growth of this unique organization.”

Please join us in extending a warm welcome to Regan Lohman as she embarks on this pivotal role within our organization. We eagerly anticipate the invaluable contributions she will bring to our board and our continued success.